Navigation Links
Blue Dye Halts Worsening Paralysis in Animal Study
Date:7/28/2009

Discovery could lead to new treatments for people with spine injuries

TUESDAY, July 28 (HealthDay News) -- The food additive that makes M&Ms and Gatorade blue may help prevent the secondary damage that occurs after a spinal cord injury, a new study suggests.

Researchers say that the dye, called Brilliant Blue G (BBG), stops the cascade of molecular events that can expand the area of injury and permanently worsen paralysis.

This finding builds on landmark research that detailed how ATP, the vital energy source that keeps the body's cells alive, pours into the area around a spinal cord injury, killing off healthy and uninjured cells. This previous research also laid out a potential way to stop secondary spinal injury: use oxidized ATP to block the ATP, according to background information provided in a news release from the University of Rochester.

Rats with damaged spinal cords that were injected with oxidized ATP recovered much of their limb function and were able to effectively, if not gracefully, walk again, the earlier research found.

The new study has found a compound that does the same thing, and it doesn't have to be injected directly into the injured spinal cord to work, the study authors explain in their report, published online in this week's issue of the Proceedings of the National Academy of Sciences.

"While we achieved great results when oxidized ATP was injected directly into the spinal cord, this method would not be practical for use with spinal cord-injured patients," said lead researcher Dr. Maiken Nedergaard, a professor of neurosurgery and director of the Center for Translational Neuromedicine at the University of Rochester Medical Center.

"First, no one wants to put a needle into a spinal cord that has just been severely injured, so we knew we needed to find another way to quickly deliver an agent that would stop ATP from killing healthy motor neurons. Second, the compound we initially used, oxidized ATP, cannot be injected into the bloodstream because of its dangerous side effects," Nedergaard explained in the news release.

In the search for a compound that would thwart ATP attacks and could be administered intravenously, Nedergaard stumbled upon BBG.

An intravenous injection of BBG significantly reduced secondary injury in spinal cord-injured rats, which improved to the point of being able to walk again, although with a limp. There was a side effect, however. Injected rats had a blue tinge to their skin for a while.

While more study is needed, Nedergaard and longtime collaborator Dr. Steven Goldman, chair of the University of Rochester Department of Neurology, hope that BBG and related agents will yield new treatments for acute spinal cord injuries.

More information

The U.S. National Institutes of Health offers information on spinal cord injuries.



--Dennis Thompson



SOURCE: University of Rochester, news release, July 27, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Photo: New Data Show Gleevec(R) Halts Progression to Advanced Stages of Life-Threatening Form of Leukemia in Sixth Year of Treatment
2. Scripps research scientists find new genetic mutation that halts the development of lupus
3. Experimental Vaccine Halts Prostate Cancer in Mice
4. Manufacturer Halts Production of Blood Thinner Heparin
5. St. Jude finds signaling system that halts the growth of a childhood brain cancer
6. Surgical technique halts cell loss, Parkinsons researchers find
7. PA Department of Health Halts Admissions at Commonwealth Medical Center in Beaver County
8. Gastric Bypass Halts Diabetes in Obese Teens
9. Kellogg Halts Sales of Peanut Butter Crackers
10. FDA Halts New Applications From Indian Drug Makers Plant
11. Interferon does not slow or stop hepatitis C from worsening, study finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blue Dye Halts Worsening Paralysis in Animal Study
(Date:10/12/2017)... ... 12, 2017 , ... Dr. Parsa Mohebi, the Los Angeles ... to the newly revamped Cosmetic Town journal section, featuring articles written ... known as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... one of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. ... awards program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in property taxes a year. In some states—like New York, New Jersey, Massachusetts, ... contrast, many overseas retirement havens have extremely low property-tax rates, which contributes to ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of California Berkeley, and other leading institutions in announcing the launch of the ... to change the way animals are raised for food. , Founding members of ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... DIEGO , Oct. 12, 2017 AVACEN ... recognized the company with their  2017 New Product Innovation Award ... based on extensive primary and secondary medical device market research ... Medical, through its first-to-market OTC, drug-free pain relief product, the ... unique approach to treating fibromyalgia widespread pain. ...
(Date:10/12/2017)... , Oct. 12, 2017 West Pharmaceutical ... innovative solutions for injectable drug administration, today announced that ... market opens on Thursday, October 26, 2017, and will ... and business expectations at 9:00 a.m. Eastern Time. To ... 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... IRVING, Texas , Oct. 11, 2017  Caris ... science focused on fulfilling the promise of precision medicine, ... Institute has joined Caris, Precision Oncology Alliance™ (POA) as ... leading cancer centers, the St. Jude Crosson Cancer Institute ... to advance the use of tumor profiling, making cancer ...
Breaking Medicine Technology: